XPeng's Korea Leadership Hire and Robotaxi Green Light Add Weight to October's 50,237-Vehicle Record
SanDisk's $88.9 Billion Backlog Draws a Strong Buy While a Rival Analyst Steps Back
Palantir's Revenue Engine Is Racing Ahead of Its Order Book
Nokia's Satellite Pact With ICEYE Eyes Ukraine as AI Networking Orders Surge
Bloom Energy Rebounds 5% as Wyoming Site Clears Pre-Development and Fuel-Cell Pipeline Swells
Marvell's Data Center Engine Meets Its December 1 Audit
AMD's Data-Center Pivot Is Winning the Argument, Not Yet the Valuation
IonQ's $3.7 Billion War Chest Meets a Harder Scoreboard
BYD Faces Brussels Scrutiny as Q3 Profit Growth Falls Short of Forecasts
Wienerberger's Cost-Cutting Test Comes Due on November 12
BioNTech's Return to Profit Faces a Dual Test: Forecast Delivery and Clinical Substance
JPMorgan Builds 5.08% Vonovia Stake Through Derivatives as Landlord Tightens Spending
Healthineers Bets Its New Name on an Earnings Story Still Unproven
Micron's Roadmap Is the Real Story Behind a 5.5% Relief Rally
Equinor's Visund Outage Clouds an Otherwise Upbeat Analyst Picture
Sanofi Draws Fresh Analyst Targets as Dupixent Powers Upgraded Outlook
RWE Clears Permits for Two Hydrogen-Ready Plants as Lingen Turbine Test Fires Up
Modine's Order Boom Meets Its Margin Test as New Leadership Takes the Reins
LVMH's Parisian Makeover Comes With a Judicial Knock at the Door
AppLovin's 11% Surge Draws a Divided Analyst Reception as Nevada Move and Class Action Loom
Aixtron's Laser Order Book Doubles as JPMorgan Trims Its Target
Plug Power Traders Brace for a 21% Swing as November 9 Earnings Loom
Roche's Product Pipeline Is Firing on All Cylinders — UBS Just Says the Market Already Knows
D-Wave Quantum: IonQ's Blowout Quarter Fuels a 19% Rally, but the Real Test Lands on November 10
Vertiv Rides the AI Rebound as Execution Becomes the Only Question That Matters
Paderborn Library Tests Tilt Chairs and Anti-Fatigue Mats in Bid to Get Desk Workers Moving
Kontron's EUR 68.6 Million Question: Can Deferred Deliveries Back the 2026 Guidance?
Fermi's TensorWave Lease Still Pending as Boardroom Feud Escalates
Same Price Target, Opposite Calls: Pfizer Analysts Split After Raised Guidance
Chip ETF Rebound Masks a Brutal Month as Ballot-Box Fears Reshape the AI Trade
Redcare Pharmacy Crosses 15 Million Active Customers as Analysts Split on Price Targets
Bayer Balances a Wider Loss Against a Brighter Outlook and a Chinese First
Barrick's November 9 Reckoning: Can a Gold Tailwind Survive Contact With the P&L?